EBITDA (Quarterly)

EBITDA: Income before interest, taxes, depreciation and amortization.

Nutex Health Inc. (NUTX) had EBITDA of $86.76M for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$216.49M
Net Income	$46.81M
Cost of Goods Sold	$124.75M
Gross Profit	$91.73M
Operating Expenses	$135.22M
Operating Income	$81.27M
Non-Operating Income/Expense	$-4.71M
Pre-Tax Income	$76.56M
Normalized Pre-Tax Income	$76.56M
Income after Taxes	$62.76M
Income from Continuous Operations	$62.76M
Consolidated Net Income/Loss	$62.76M
Normalized Income after Taxes	$62.76M
EBIT	$81.27M
EBITDA	$86.76M
Weighted-Average Shares Outstanding (Basic)	6.99M
Weighted-Average Shares Outstanding (Diluted)	7.18M
Earnings per Share (EPS) (Basic)	$6.70
Earnings per Share (EPS) (Diluted)	$6.52
Balance Sheet Financials
Current Assets	$579.65M
Property, Plant, and Equipment	$94.93M
Long-Term Assets	$377.67M
Total Assets	$957.32M
Current Liabilities	$184.44M
Long-Term Debt	$293.04M
Long-Term Liabilities	$330.83M
Total Liabilities	$515.26M
Common Equity	$442.05M
Tangible Shareholders Equity	$407.23M
Shareholders Equity	$442.05M
Common Shares Outstanding	6.95M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$75.52M
Cash Flow from Investing Activities	$-1.20M
Cash Flow from Financial Activities	$-49.55M
Beginning Cash	$185.87M
End Cash	$210.64M
Increase/Decrease in Cash	$24.77M
Stock-Based Compensation	$-3.92M
Common Stock Dividends Paid	$-15.36M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.14
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.40
Debt to Equity Ratio	0.72
Gross Margin	42.37%
Operating Margin	37.54%
EBIT Margin	37.54%
EBITDA Margin	--
Pre-Tax Profit Margin	35.37%
Profit Margin	21.62%
Free Cash Flow	$74.32M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.23
Inventory Turnover	26.66
Receiveable Turnover	0.63
Days Sales in Receivables	143.80
Return on Equity	14.20%
Return on Tangible Equity	15.41%
Return on Assets	6.56%
Return on Investments	8.54%
Book Value Per Share	$63.59
Free Cash Flow per Share	$10.35
Operating Cash Flow per Share	$10.52

Data from Zacks Investment Research, Inc.